ExL Events’ 10th REMS Summit is the premier life science event for REMS professionals to learn the latest in regulatory changes, the best of emerging technologies and tools, and strategies for capitalizing on sweeping trends.
Consider sponsoring or exhibiting at this event if your organization is interested in networking and forming lasting relationships with industry executives. Learn more by contacting Justin Kreamer at 917-932-0429 or email@example.com.
BioTrak Research Inc. (“BioTrak”) has for over 18 years applied its proven experience in fielding, data collection, analysis, and reporting of drug safety and appropriate use studies to the pharmaceutical industry. This work encompassed not only 50 FDA REMS programs and over 90 REMS assessment reports, but also the application of Failure Modes and Effects Analysis (FMEA) and other tools in support of labeling comprehension studies, usability testing, and human factors research studies.
BioTrak has in its history completed more than 400 survey and interview-based research studies and more than 200 web-based questionnaire survey studies with health care providers, pharmacists, and patients. BioTrak can be reached through www.biotrak.com.
Haug Partners is a full-service, national law firm that provides integrated multidisciplinary legal services for life science and technology companies. Our service offerings include: (i) Antitrust Litigation and Counseling; (ii) Commercial Litigation and Strategic Counseling; (iii) Due Diligence; (iv) FDA Compliance and Counseling; (v) Intellectual Property Enforcement; (vi) Intellectual Property Procurement and Strategy; (vii) International Trade Commission; (viii) Investigations, Compliance, and Risk Mitigation Services; (ix) Licensing and Transactions; and (x) Trademarks and Unfair Competition. With offices in New York, Washington, D.C., and Boston, and through working partnerships with firms in Germany, China, and Japan, Haug Partners has the resources, technical expertise, legal acumen, and business judgment to consistently deliver optimal outcomes for clients. The firm was founded in 1997 as Frommer Lawrence and Haug and adopted the Haug Partners name in March 2017.
McKesson Specialty Health
McKesson Specialty Health, a division of McKesson Corporation, empowers the community patient care delivery system by helping community practices advance the science, technology and quality of care. Through innovative clinical, research, business and operational solutions, facilitated by integrated technology systems, we focus on improving the financial health of our customers so they may provide the best care to their patients. For more information, visit www.mckessonspecialtyhealth.com/.
United BioSource Corporation (UBC), a subsidiary of Express Scripts Holding Company, leads the market in providing integrated, comprehensive clinical, safety, and commercialization services. Working with Express Scripts’ specialty pharmacy and specialty distribution organizations, UBC is uniquely positioned to seamlessly integrate best-in-class services throughout the life cycle of a product.